FHETX
Price
$18.63
Change
-$0.08 (-0.43%)
Updated
Sep 20 closing price
VGSIX
Price
$32.50
Change
-$0.12 (-0.37%)
Updated
Sep 20 closing price
Ad is loading...

FHETX vs VGSIX

Header iconFHETX vs VGSIX Comparison
Open Charts FHETX vs VGSIXBanner chart's image
Fidelity Advisor Real Estate M
Price$18.63
Change-$0.08 (-0.43%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Investor
Price$32.50
Change-$0.12 (-0.37%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FHETX vs VGSIX Comparison Chart
Loading...
VS
FHETX vs. VGSIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHETX is a StrongSell and VGSIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGSIX has more cash in the bank: 70.5B vs. FHETX (245M). VGSIX pays higher dividends than FHETX: VGSIX (3.85) vs FHETX (1.99). FHETX was incepted earlier than VGSIX: FHETX (22 years) vs VGSIX (28 years). FHETX is a more actively managed with annual turnover of: 31.00 vs. VGSIX (9.00). FHETX has a lower initial minimum investment than VGSIX: FHETX (0) vs VGSIX (3000). VGSIX (30.65) and FHETX (30.02) have marching annual gain over last year. VGSIX return over 5 years is better than : 25.45 vs. FHETX (-16.28).
FHETXVGSIXFHETX / VGSIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years28 years-
Gain YTD12.58112.97997%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets245M70.5B0%
Annual Yield % from dividends1.993.8552%
Returns for 1 year30.0230.6598%
Returns for 3 years-20.663.36-614%
Returns for 5 years-16.2825.45-64%
Returns for 10 years3.0286.343%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIDU2.750.09
+3.38%
Sidus Space
TUSK3.920.09
+2.35%
Mammoth Energy Services
ADNT22.670.08
+0.35%
Adient plc
NICE164.89-0.94
-0.57%
NICE Ltd
PLRX12.15-0.47
-3.72%
Pliant Therapeutics